Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
Quest Diagnostics' (DGX) Base Business Grows Despite Margin Woes
02:33pm, Friday, 01'st Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) continues to make inroads with its health plans, gaining share and increasing revenues faster than the market.
BD's (BDX) New Combination Test to Boost Patient Outcome
02:15pm, Friday, 01'st Jul 2022 Zacks Investment Research
BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.
Catalent (CTLT) Expands Packaging Capabilities at Japan Facility
03:14pm, Thursday, 30'th Jun 2022 Zacks Investment Research
Catalent's (CTLT) latest capability expansion is expected to boost its business in this key hub in its Asia-Pacific Clinical Supply Services network.
Exact Sciences (EXAS) Cologuard Growth Robust Amid Margin Woes
02:20pm, Thursday, 30'th Jun 2022 Zacks Investment Research
Exact Sciences' (EXAS) legacy Screening business is growing on impressive Cologuard volume growth and revenue contributions from the PreventionGenetics acquisition.
Cardinal Health (CAH) Ties Up to Deliver Products Via Drones
05:25pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Cardinal Health's (CAH) latest collaboration is expected to significantly boost its distribution strategy and improve patient service.
3 Reasons to Retain Catalent (CTLT) Stock in Your Portfolio
05:03pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.
Omnicell (OMCL) Up 10% Since Q1 Earnings: What's Driving It?
04:41pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Investors are optimistic about Omnicell's (OMCL) strategic partnerships and continued innovations for the Autonomous Pharmacy.
Illumina's (ILMN) GRAIL to Offer Galleri Test in Indianapolis
04:39pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Illumina's (ILMN) division GRAIL will offer the Galleri MCED blood test to eligible patients across the Community Health Network's care sites.
ENOV vs. OMCL: Which Stock Should Value Investors Buy Now?
03:40pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
ENOV vs. OMCL: Which Stock Is the Better Value Option?
Omnicell (OMCL) Up 10% Since Q1 Earnings: What's Driving It?
01:55pm, Wednesday, 29'th Jun 2022
Investors are optimistic about Omnicell's (OMCL) strategic partnerships and continued innovations for the Autonomous Pharmacy.
ENOV vs. OMCL: Which Stock Should Value Investors Buy Now?
01:09pm, Wednesday, 29'th Jun 2022
ENOV vs. OMCL: Which Stock Is the Better Value Option?
Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?
10:20am, Wednesday, 29'th Jun 2022 Zacks Investment Research
Style Box ETF report for SLYG
3 Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
03:29pm, Tuesday, 28'th Jun 2022 Zacks Investment Research
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Amedisys' (AMED) New Tie Up to Boost At-Home Patient Care
03:20pm, Tuesday, 28'th Jun 2022 Zacks Investment Research
Amedisys (AMED) strengthens its Home Health and Hospice business reach by partnering with Memorial Hermann.
Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
03:34pm, Monday, 27'th Jun 2022 Zacks Investment Research
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
